CAS No |
Product Name |
Molecular Formula |
2366209-97-2
|
6-Bromo-1-phenylnaphthalene
|
C16H11Br
|
2366210-03-7
|
2-(4-Chlorophenyl)-1-phenylnaphthalene
|
C22H15Cl
|
2369979-68-8
|
JHU37160 (DREADD ligand);3-chloro-6-(4-ethylpiperazin-1-yl)-10-fluoro-11H-benzo(b)(1,4)benzodiazepine
|
C19H20ClFN4
|
2375259-86-0
|
(5,5-Dimethyl-3-pyrrolidinyl)acetic acid hydrochloride
|
C8H16ClNO2
|
2375281-44-8
|
NF-kappaBeta activator 2;3-(2-(2-fluoroanilino)-1,3-oxazol-5-yl)benzoic acid
|
C16H11FN2O3
|
2375421-09-1
|
SR-717 lithium;lithium 4,5-difluoro-2-((6-imidazol-1-ylpyridazine-3-carbonyl)amino)benzoate
|
C15H8F2LiN5O3
|
2375865-91-9
|
Rosuvastatin Impurity 18;tert-butyl 2-((4S,6R)-6-(acetoxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetate
|
C15H26O6
|
2376990-29-1
|
Thalidomide-O-C4-NH2 (hydrochloride);4-(4-Aminobutoxy)-2-(2,6-dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione hydrochloride (1:1)
|
C17H20ClN3O5
|
2377770-18-6
|
(2-(3,6-Dimethoxy-9H-carbazol-9-yl)ethyl)phosphonic acid
|
C16H18NO5P
|
2378356-17-1
|
2'-(9H-Carbazol-9-yl)-(1,1'-biphenyl)-4-amine;4-(2-carbazol-9-ylphenyl)aniline
|
C24H18N2
|
2379402-85-2
|
Bortezomib Impurity 5;Deu3MZ2AN8;(S)-N-(1-(3-hydroxy-3-methylbutanamido)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide
|
C19H22N4O4
|
2379694-79-6
|
1,10-Phenanthroline-3,8-dicarboxylic acid
|
C14H8N2O4
|
2380027-49-4
|
Src Inhibitor 3;N-(3-chloro-4-((6-methoxypyrazolo(1,5-a)pyridine-3-carbonyl)amino)phenyl)-1-(1-(3-cyano-3-methylbutanoyl)piperidin-4-yl)-5-fluoroindazole-3-carboxamide
|
C34H32ClFN8O4
|
2380230-73-7
|
2-(2-((3-(4-((4-Methylpiperazin-1-yl)methyl)phenyl)phenyl)carbonylamino)phenyl)ethanoic acid
|
C27H29N3O3
|
2381400-91-3
|
2-Methyl-2-propanyl (4S)-4-amino-3,3-difluoro-1-pyrrolidinecarboxylate;(4S)-4-Amino-3,3-difluoro-1-pyrrolidinecarboxylate de 2-m�thyl-2-propanyle
|
C9H16F2N2O2
|
2381854-90-4
|
Fmoc-N-Me-3-(4-py)-L-Ala;(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-3-(pyridin-4-yl)propanoic acid
|
C24H22N2O4
|
2384108-14-7
|
Cefazolin EP Impurity B;Cefazolin pivaloyl; (6R,7R)-7-(2,2-dimethylpropanoylamino)-3-((5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid
|
C16H20N4O4S3
|
2387518-94-5
|
4-((1,2,4)Triazolo(1,5-a)pyridin-7-yloxy)-2-fluoro-3-methylaniline;2-fluoro-3-methyl-4-((1,2,4)triazolo(1,5-a)pyridin-7-yloxy)aniline
|
C13H11FN4O
|
2387538-18-1
|
2-Chloro-4-neopentylpyridine
|
C10H14ClN
|
2387728-91-6
|
1-(4-Ethoxy-3-(hydroxymethyl)phenyl)-2-((2-methyl-2-propanyl)amino)ethanol
|
C15H25NO3
|
2389125-23-7
|
Y6-BO-4F;2-((2Z)-2-((23-((Z)-(1-(dicyanomethylidene)-5,6-difluoro-3-oxoinden-2-ylidene)methyl)-3,27-di(undecan-5-yl)-8,22-di(undecyl)-6,10,15,20,24-pentathia-3,14,16,27-tetrazaoctacyclo(16.9.0.02,12.04,11.05,9.013,17.019,26.021,25)heptacosa-1(18),2(12),4(11),5(9),7,13,16,19(26),21(25),22-decaen-7-yl)methylidene)-5,6-difluoro-3-oxoinden-1-ylidene)propanedinitrile
|
C88H98F4N8O2S5
|
2392930-05-9
|
2-Chloro-4,6-di(dibenzofuran-1-yl)-1,3,5-triazine
|
C27H14ClN3O2
|
2396570-49-1
|
2,4,6-Tris(4-(1H-pyrazol-4-yl)phenyl)-1,3,5-triazine
|
C30H21N9
|
2402776-84-3
|
Baricitinib Impurity 16;2-(3-(4-(1-(3-(Cyanomethyl)-1-(ethylsulfonyl)azetidin-3-yl)-1H-pyrazol-4-yl)-7H-pyrrolo(2,3-d)pyrimidin-7-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile
|
C23H27N9O4S2
|
2408053-56-3
|
Sacubitril Methyl Ester;4-(((2S,4R)-1-((1,1'-Biphenyl)-4-yl)-5-methoxy-4-methyl-5-oxopentan-2-yl)amino)-4-oxobutanoic acid
|
C23H27NO5
|
2408294-08-4
|
Methanesulfonato 1,1'-Bis(di-tert-butylphosphino) ferrocene (2'-amino-1,1'-biphenyl-2-yl) palladium(II)
|
C39H49FeNO3P2PdS
|
2408495-96-3
|
Budesonide 21-Butyrate Impurity;(2-((1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-9,13-dimethyl-16-oxo-6-propyl-5,7-dioxapentacyclo(10.8.0.02,9.04,8.013,18)icosa-14,17-dien-8-yl)-2-oxoethyl) butanoate
|
C29H40O7
|
2408968-92-1
|
(1-(Aminomethyl)-2-oxabicyclo(3.1.1)heptan-5-yl)methanol hydrochloride
|
C8H16ClNO2
|
2409005-96-3
|
3-(5-Bromo-6-fluoro-1-oxoisoindolin-2-yl)piperidine-2,6-dione;3-(6-bromo-5-fluoro-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione
|
C13H10BrFN2O3
|
2409479-29-2
|
(R)-1-(4-(1-(2-((6-(6-(Dimethylamino)pyrimidin-4-yl)-1H-benzo(d)imidazol-2-yl)amino)pyridin-4-yl)ethyl)piperazin-1-yl)-3,3,3-trifluoropropan-1-one;BAY-985
|
C27H30F3N9O
|
2409562-95-2
|
1-Bromo-5-(tert-butyl)-2,3-dichlorobenzene
|
C10H11BrCl2
|
2410075-48-6
|
7-Ketoabiraterone acetate;((3S,8R,9S,10R,13S,14S)-10,13-dimethyl-7-oxo-17-pyridin-3-yl-1,2,3,4,8,9,11,12,14,15-decahydrocyclopenta(a)phenanthren-3-yl) acetate
|
C26H31NO3
|
2410284-90-9
|
Nintedanib Impurity 33;Dimethyl 3,3'-(((((2,2'-(piperazine-1,4-diyl)bis(acetyl))bis(methylazanediyl))bis(4,1-phenylene))bis(azanediyl))bis(phenylmethanylylidene))(3Z,3'E)-bis(2-oxoindoline-6-carboxylate)
|
C56H52N8O8
|
2410401-58-8
|
N-(Dibenzo(b,d)furan-3-yl)-9-phenyl-9H-carbazol-2-amine
|
C30H20N2O
|
2413185-88-1
|
Oseltamivir Impurity 13;Ethyl (1S,5S,6S)-5-(Pentan-3-yloxy)-7-oxabicyclo(4.1.0)hept-3-ene-3-carboxylate
|
C14H22O4
|
2414245-11-5
|
(E,3S,5R)-7-(4-(4-fluorophenyl)-2-(methyl(methylsulfonyl)amino)-6-propan-2-ylpyrimidin-5-yl)-3,5-dihydroxyhept-6-enoate calcium
|
C44H54CaF2N6O12S2
|
2414962-06-2
|
Amlodipine EP Impurity D HCl;3-Ethyl 5-methyl 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-6-methylpyridine-3,5-dicarboxylate hydrochloride
|
C20H24Cl2N2O5
|
2415937-32-3
|
4-Iodobenzoyl fluoride
|
C7H4FIO
|
2416949-69-2
|
Linagliptin Impurity 7;(R)-N-(2-acetylphenyl)-2-(8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)acetamide
|
C25H29N7O4
|
2421187-79-1
|
N6-((2-(3-Methyl-3H-diazirin-3-yl)ethoxy)carbonyl)-L-lysine hydrochloride
|
C11H21ClN4O4
|
2434843-97-5
|
5-((1R,4R)-2-oxa-5-azabicyclo(2.2.1)heptan-5-yl)pyrazolo(1,5-a)pyrimidine-3-carboxylic acid;5-((1R,4R)-2-oxa-5-azabicyclo(2.2.1)heptan-5-yl)pyrazolo(1,5-a)pyrimidine-3-carboxylic acid
|
C12H12N4O3
|
2436760-81-3
|
Befiradol hydrochloride;(3-chloro-4-fluorophenyl)-(4-fluoro-4-(((5-methylpyridin-2-yl)methylamino)methyl)piperidin-1-yl)methanone;hydrochloride
|
C20H23Cl2F2N3O
|
2436762-89-7
|
8-Bromo-1,7-di(but-2-yn-1-yl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione;Linagliptin Impurity 55;1H-Purine-2,6-dione, 8-bromo-1,7-di-2-butyn-1-yl-3,7-dihydro-3-methyl
|
C14H13BrN4O2
|
2439164-91-5
|
cabozantinibimpurity16;1-N,1-N'-bis(4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl)cyclopropane-1,1-dicarboxamide
|
C39H34N4O8
|
2446474-09-3
|
Pomalidomide-PEG3-Amine HCl salt;4-(2-(2-(2-(2-aminoethoxy)ethoxy)ethoxy)ethylamino)-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione;hydrochloride
|
C21H29ClN4O7
|
2446799-72-8
|
Linagliptin Impurity 64;(R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-2-((4-methylquinazolin-2-yl)methoxy)-3,7-dihydro-6H-purin-6-one
|
C25H28N8O2
|
2448346-01-6
|
Cinacalcet impurity 23;(R)-N-(1-(naphthalen-1-yl)ethyl)-3-(m-tolyl)propanamide
|
C22H23NO
|
2452301-09-4
|
Empagliflozin Methyl Acetate;((2R,3S,4R,5R,6S)-6-(4-chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)methyl acetate
|
C25H29ClO8
|
2454396-80-4
|
2,4,7-Trichloro-8-fluoropyrido(4,3-d)pyrimidine
|
C7HCl3FN3
|
2454397-74-9
|
Ethyl 4-amino-6-chloro-5-fluoronicotinate
|
C8H8ClFN2O2
|